Literature DB >> 16539862

Is serotonin hyperalgesic or analgesic?

Claudia Sommer1.   

Abstract

Serotonin (5-hydroxtryptamine, 5-HT) is an important molecule in pain processing and modulation. Whether 5-HT has an analgesic or hyperalgesic action depends on the cell type and type of receptor it acts on. In the periphery, 5-HT sensitizes afferent nerve fibers, thus contributing to hyperalgesia in inflammation and nerve injury. In the trigeminal system, agonism at 5-HT1B/D receptors reduces neurotransmitter release, but actions through the 5-HT2A receptor may underlie chronic headache. Furthermore, genetic alterations in the 5-HT system may influence the susceptibility to migraine. In the central nervous system, 5-HT is involved in descending inhibition, but facilitatory serotonergic pathways may be functionally more important.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16539862     DOI: 10.1007/s11916-006-0020-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  72 in total

Review 1.  Descending control of pain.

Authors:  Mark J Millan
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

2.  The release of serotonin in rat spinal dorsal horn and periaqueductal gray following carrageenan inflammation.

Authors:  Y Q Zhang; X Gao; L M Zhang; G C Wu
Journal:  Neuroreport       Date:  2000-11-09       Impact factor: 1.837

Review 3.  Spinal and supraspinal contributions to central sensitization in peripheral neuropathy.

Authors:  Rie Suzuki; Anthony Dickenson
Journal:  Neurosignals       Date:  2005

4.  2002 Wolff Award. 5 -HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks.

Authors:  Anan Srikiatkhachorn; Chalalai Suwattanasophon; Unchalee Ruangpattanatawee; Pansiri Phansuwan-Pujito
Journal:  Headache       Date:  2002 Jul-Aug       Impact factor: 5.887

5.  An interaction of inflammatory mediators and protons in small diameter dorsal root ganglion neurons of the rat.

Authors:  M Kress; P W Reeh; L Vyklicky
Journal:  Neurosci Lett       Date:  1997-03-07       Impact factor: 3.046

6.  Chemosensitivity of fine afferents from rat skin in vitro.

Authors:  E Lang; A Novak; P W Reeh; H O Handwerker
Journal:  J Neurophysiol       Date:  1990-04       Impact factor: 2.714

7.  Persisting sensitization of the behavioural response to formalin-induced injury in the rat through activation of serotonin2A receptors.

Authors:  F V Abbott; Y Hong; P Blier
Journal:  Neuroscience       Date:  1997-03       Impact factor: 3.590

8.  Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.

Authors:  D Bengel; D L Murphy; A M Andrews; C H Wichems; D Feltner; A Heils; R Mössner; H Westphal; K P Lesch
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

Review 9.  Bad news from the brain: descending 5-HT pathways that control spinal pain processing.

Authors:  Rie Suzuki; Lars J Rygh; Anthony H Dickenson
Journal:  Trends Pharmacol Sci       Date:  2004-12       Impact factor: 14.819

Review 10.  Neurobiology in primary headaches.

Authors:  Lars Edvinsson; Rolf Uddman
Journal:  Brain Res Brain Res Rev       Date:  2004-11-18
View more
  20 in total

1.  Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding.

Authors:  Marie Deen; Anders Hougaard; Hanne Demant Hansen; Martin Schain; Agnete Dyssegaard; Gitte Moos Knudsen; Messoud Ashina
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

2.  Experimental Disc Herniation in the Rat Causes Downregulation of Serotonin Receptor 2c in a TNF-dependent Manner.

Authors:  Daniel Jonsson; Oscar Finskas; Yuki Fujioka; Anders Ståhlberg; Kjell Olmarker
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

3.  Nutraceutical preparations in childhood migraine prophylaxis: effects on headache outcomes including disability and behaviour.

Authors:  Maria Esposito; Maria Ruberto; Antonio Pascotto; Marco Carotenuto
Journal:  Neurol Sci       Date:  2012-03-23       Impact factor: 3.307

4.  Effects of opioids on human serotonin transporters.

Authors:  M Barann; U M Stamer; M Lyutenska; F Stüber; H Bönisch; B Urban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-22       Impact factor: 3.000

Review 5.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 6.  Serotonin and migraine: a reconsideration of the central theory.

Authors:  Alessandro Panconesi
Journal:  J Headache Pain       Date:  2008-07-31       Impact factor: 7.277

7.  Effects of Palonosetron, a 5-HT3 Receptor Antagonist, on Mechanical Allodynia in a Rat Model of Postoperative Pain.

Authors:  Ki Tae Jung; Myung Ha Yoon; Hyun Young Lee; Bo Yeon Yu; Dong Kyu Kim; Kyung Joon Lim
Journal:  Korean J Pain       Date:  2013-04-03

8.  Differential associations between brain 5-HT(1A) receptor binding and response to pain versus touch.

Authors:  Ilkka K Martikainen; Jussi Hirvonen; Ullamari Pesonen; Nora Hagelberg; Heikki Laurikainen; Heikki Tuikkala; Jaana Kajander; Kjell Någren; Jarmo Hietala; Antti Pertovaara
Journal:  J Neural Transm (Vienna)       Date:  2009-06-17       Impact factor: 3.575

9.  Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans.

Authors:  Eva Kosek; Karin B Jensen; Tina B Lonsdorf; Martin Schalling; Martin Ingvar
Journal:  Mol Pain       Date:  2009-07-01       Impact factor: 3.395

10.  Serotonin-1A receptor polymorphism (rs6295) associated with thermal pain perception.

Authors:  Fredrik Lindstedt; Bianka Karshikoff; Martin Schalling; Caroline Olgart Höglund; Martin Ingvar; Mats Lekander; Eva Kosek
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.